Comments on: Corona vaccine CVnCoV Bad interim result for CureVac Setback for CureVac: The corona vaccine CVnCoV only showed an effectiveness of 47 percent in the second interim analysis, said the Tübingen-based company. The study is to be continued.

Comments on: Corona vaccine CVnCoV Bad interim result for CureVac Setback for CureVac: The corona vaccine CVnCoV only showed an effectiveness of 47 percent in the second interim analysis, said the Tübingen-based company. The study is to be continued. https://en.spress.net/corona-vaccine-cvncov-bad-interim-result-for-curevac-setback-for-curevac-the-corona-vaccine-cvncov-only-showed-an-effectiveness-of-47-percent-in-the-second-interim-analysis-said-the-tubingen-based-c/ Spress is a general newspaper in English which is updated 24 hours a day. Tue, 22 Jun 2021 08:51:11 +0000 hourly 1